AGAMREE 40mg/ml oral suspension SANTHERA
vamorolone Indicated for: Duchenne muscular dystrophy
letter A · page 27
vamorolone Indicated for: Duchenne muscular dystrophy
pentoxifylline Indicated for: peripheral vascular disease; circulatory disorders
vildagliptin Indicated for: type 2 diabetes mellitus
vildagliptin + metformin Indicated for: type 2 diabetes mellitus
vildagliptin + metformin Indicated for: type 2 diabetes mellitus
amlodipine Indicated for: hypertension
amlodipine Indicated for: hypertension
amprenavir Indicated for: HIV-1 infection
J05AE05 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
amprenavir Indicated for: HIV-1 infection
J05AE05 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
amprenavir Indicated for: HIV-1 infection
J05AE05 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
tirofiban Indicated for: prevention of atherothrombotic events
acetylsalicylic acid + dipyridamole Indicated for: cardiovascular prevention
ispaghula seed + ispaghula husk Indicated for: constipation; regulation of bowel transit
sennosides Indicated for: constipation
chaste tree fruit extract Indicated for: premenstrual syndrome; menstrual cycle disorders
G02CX03 Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals
aflibercept Indicated for: macular degeneration; diabetic macular edema
S01LA05 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
erenumab Indicated for: migraine
N02CX07 Nervous system | Antimigraine preparations | Other antimigraine preparations
erenumab Indicated for: migraine
erenumab Indicated for: migraine
N02CX07 Nervous system | Antimigraine preparations | Other antimigraine preparations
montelukast Indicated for: asthma; allergic rhinitis